share_log

MAI Capital Management Sells 424 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

MAI Capital Management Sells 424 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

邁資本管理公司出售直覺外科公司股份有限公司(納斯達克代碼:ISRG)424股
Defense World ·  2022/10/01 05:51

MAI Capital Management lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 10.2% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 3,722 shares of the medical equipment provider's stock after selling 424 shares during the period. MAI Capital Management's holdings in Intuitive Surgical were worth $747,000 at the end of the most recent quarter.

據麥資本管理公司最近提交給美國證券交易委員會的13F文件顯示,該公司在第二季度減持了直覺外科公司股份有限公司(代碼:ISRG-GET)10.2%。該公司在此期間出售了424股後,擁有這家醫療設備提供商的3722股股票。截至最近一個季度末,麥氏資本管理公司持有的直覺外科公司股份價值747,000美元。

A number of other hedge funds have also bought and sold shares of the company. Investment Partners LTD. boosted its position in shares of Intuitive Surgical by 4.8% during the first quarter. Investment Partners LTD. now owns 768 shares of the medical equipment provider's stock valued at $232,000 after buying an additional 35 shares during the period. Transcend Capital Advisors LLC increased its position in shares of Intuitive Surgical by 4.9% during the first quarter. Transcend Capital Advisors LLC now owns 880 shares of the medical equipment provider's stock worth $265,000 after acquiring an additional 41 shares during the period. BLB&B Advisors LLC boosted its holdings in shares of Intuitive Surgical by 6.9% in the first quarter. BLB&B Advisors LLC now owns 693 shares of the medical equipment provider's stock valued at $209,000 after purchasing an additional 45 shares during the period. Venture Visionary Partners LLC raised its position in Intuitive Surgical by 1.5% during the 1st quarter. Venture Visionary Partners LLC now owns 3,024 shares of the medical equipment provider's stock valued at $912,000 after purchasing an additional 45 shares in the last quarter. Finally, Douglass Winthrop Advisors LLC increased its stake in shares of Intuitive Surgical by 2.0% during the first quarter. Douglass Winthrop Advisors LLC now owns 2,308 shares of the medical equipment provider's stock valued at $696,000 after buying an additional 46 shares during the period. Institutional investors own 82.44% of the company's stock.

其他一些對衝基金也買賣了該公司的股票。投資夥伴有限公司第一季度將其持有的直覺外科公司股票的頭寸提高了4.8%。投資夥伴有限公司在此期間又購買了35股後,現在擁有768股這家醫療設備提供商的股票,價值23.2萬美元。Beyond Capital Advisors LLC在第一季度增持了4.9%的直覺外科公司股票。Transcend Capital Advisors LLC在此期間額外收購了41股,現在擁有880股這家醫療設備提供商的股票,價值265,000美元。今年第一季度,BLB&B Advisors LLC增持了6.9%的直覺外科公司股票。BLB&B Advisors LLC現在擁有這家醫療設備提供商693股股票,價值20.9萬美元,在此期間又購買了45股。第一季度,Venture Visionary Partners LLC將其在直覺外科公司的持股比例提高了1.5%。Venture Visionary Partners LLC現在擁有這家醫療設備提供商3,024股股票,價值912,000美元,上個季度又購買了45股。最後,道格拉斯·温斯羅普顧問有限責任公司在第一季度增持了直覺外科公司的股份,增幅為2.0%。道格拉斯·温斯羅普顧問公司現在擁有這家醫療設備提供商2,308股股票,價值696,000美元,在此期間又購買了46股。機構投資者持有該公司82.44%的股票。

Get
到達
Intuitive Surgical
直覺外科公司
alerts:
警報:

Insider Transactions at Intuitive Surgical

直覺外科公司的內幕交易

In related news, Director Amal M. Johnson sold 6,375 shares of the business's stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total value of $1,517,505.00. Following the completion of the transaction, the director now directly owns 11,224 shares in the company, valued at approximately $2,671,760.96. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, EVP Myriam Curet sold 9,000 shares of the business's stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the sale, the executive vice president now owns 217 shares of the company's stock, valued at approximately $48,825. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the transaction, the director now directly owns 11,224 shares in the company, valued at $2,671,760.96. The disclosure for this sale can be found here. Insiders have sold 101,162 shares of company stock valued at $22,062,916 in the last 90 days. 0.90% of the stock is currently owned by company insiders.

在相關新聞中,董事在8月3日星期三的一次交易中出售了6,375股該公司的股票。這些股票的平均價格為238.04美元,總價值為1,517,505.00美元。交易完成後,董事現在直接擁有該公司11,224股,價值約2,671,760.96美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過美國證券交易委員會網站。在相關新聞中,執行副總裁Myriam Curet在7月27日星期三的一次交易中出售了9000股該公司的股票。這些股票的平均價格為225.00美元,總價值為2,025,000.00美元。出售完成後,執行副總裁總裁現在持有該公司217股股票,價值約48,825美元。這筆交易是在提交給美國證券交易委員會的法律文件中披露的,該文件可通過此超鏈接。此外,在8月3日星期三的一次交易中,董事出售了6,375股該股。這些股票的平均價格為238.04美元,總成交金額為1,517,505.00美元。交易完成後,董事現在直接擁有該公司11,224股股份,價值2,671,760.96美元。關於這次銷售的披露可以找到這裏。在過去的90天裏,內部人士已經出售了101,162股公司股票,價值22,062,916美元。公司內部人士目前持有該公司0.90%的股份。

Intuitive Surgical Stock Performance

直覺外科公司股票表現

Shares of ISRG opened at $187.44 on Friday. The business's 50-day moving average is $216.24 and its two-hundred day moving average is $230.27. The company has a market capitalization of $66.94 billion, a P/E ratio of 47.69, a P/E/G ratio of 5.36 and a beta of 1.31. Intuitive Surgical, Inc. has a fifty-two week low of $184.94 and a fifty-two week high of $369.69.
上週五,ISRG的股價開盤報187.44美元。該業務的50日移動均線切入位在216.24美元,200日移動均線切入位在230.27美元。該公司市值為669.4億美元,市盈率為47.69,市盈率為5.36,貝塔係數為1.31。直覺外科公司的股價為184.94美元,為52周低點,52周高點為369.69美元。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last issued its earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 EPS for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). The company had revenue of $1.52 billion during the quarter, compared to analysts' expectations of $1.56 billion. Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. During the same quarter in the previous year, the company earned $1.42 EPS. Analysts forecast that Intuitive Surgical, Inc. will post 3.76 EPS for the current year.

直覺外科公司(納斯達克代碼:ISRG-GET Rating)最近一次發佈收益報告是在7月21日星期四。這家醫療設備供應商公佈本季度每股收益為0.85美元,低於分析師普遍預期的1.04美元(0.19美元)。該公司本季度營收為15.2億美元,高於分析師預期的15.6億美元。直覺外科公司的股本回報率為12.04%,淨利潤率為24.05%。去年同期,該公司每股收益為1.42美元。分析師預測,直覺外科公司公司本年度每股收益將達到3.76股。

Analysts Set New Price Targets

分析師設定新的價格目標

Several equities analysts recently issued reports on ISRG shares. Evercore ISI cut their price objective on shares of Intuitive Surgical from $210.00 to $175.00 in a report on Friday, July 22nd. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $250.00 to $260.00 and gave the company a "buy" rating in a report on Friday, September 9th. Morgan Stanley decreased their target price on shares of Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating for the company in a research report on Friday, July 15th. Raymond James reduced their price target on Intuitive Surgical from $294.00 to $255.00 in a research report on Friday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on Intuitive Surgical from $225.00 to $205.00 in a research report on Friday, July 22nd. Six research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $268.00.

幾位股票分析師最近發佈了關於ISRG股票的報告。在7月22日星期五的一份報告中,Evercore ISI將直覺外科公司的股票目標價從210.00美元下調至175.00美元。9月9日,Stifel Nicolaus在一份報告中將直覺外科公司股票的目標價從250.00美元上調至260.00美元,並給予該公司“買入”評級。7月15日,摩根士丹利在一份研究報告中將直覺外科公司股票的目標價從300.00美元下調至225.00美元,併為該公司設定了“同等權重”的評級。雷蒙德·詹姆斯在7月22日星期五的一份研究報告中將直覺外科公司的目標價從294.00美元下調至255.00美元。最後,德意志銀行Aktiengesellschaft在7月22日(週五)的一份研究報告中將直覺外科公司的目標價從225.00美元下調至205.00美元。6名研究分析師對該股的評級為持有,12名分析師對該公司股票的評級為買入。根據MarketBeat的數據,該股目前的平均評級為“中等買入”,平均目標價為268.00美元。

About Intuitive Surgical

關於直覺外科公司

(Get Rating)

(獲取評級)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

直覺外科公司公司開發、製造和營銷產品,使醫生和醫療保健提供者能夠在美國和國際上提高微創護理的質量和獲得微創護理的機會。該公司提供達芬奇外科系統,以實現使用微創方法進行復雜手術;以及離子腔內系統,將其商業產品從外科擴展到能夠進行微創肺活組織檢查的診斷程序。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • Declining Profits Challenge the CarMax Value Proposition
  • How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
  • 免費獲取斯托克新聞網關於直覺外科公司的研究報告
  • 電動汽車電池製造商Freyr將在全球大舉擴張
  • MarketBeat:回顧一週9/26-9/30
  • 這是買入美光科技的難忘時刻
  • 利潤下降對CarMax價值主張的挑戰
  • Keurig Dr Pepper與規模更大的競爭對手可口可樂(Coke&Pepsi)相比如何?

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《直覺外科公司日報》的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊接收對直覺外科公司及相關公司的最新新聞和分析師評級的每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論